全膝关节置换术后住院期间阿片类药物使用:2016年至2021年消耗趋势
该回顾性队列研究纳入2016年1月至2021年4月在本机构接受初次全膝关节置换术的全部10,072例患者,分析住院期间每日阿片类药物消耗量(换算为吗啡毫克当量/天)。结果显示日消耗量从2016年的43.2±68.6 MME/天降至2021年的15.0±29.2 MME/天,呈显著线性下降趋势(每年减少5.55 MME/天,校正R方0.982,P<.001),最高VAS评分从2016年的4.45降至2021年的3.79(P<.001)。
要点
- 初次全膝关节置换术后住院期间阿片类药物日消耗量从2016年43.2±68.6 MME/天降至2021年15.0±29.2 MME/天。
- 线性回归显示术后阿片类药物消耗随时间呈显著线性下降趋势,每年减少5.55 MME/天(校正R方0.982,P<.001)。
- 最高VAS评分2016年为4.45,2021年为3.79(P<.001)。
核心结论
- 减少阿片类药物的方案已在初次全膝关节置换术后患者中实施,本研究结果表明这些方案成功降低了全膝关节置换术后住院期间的整体阿片类药物使用。
研究设计与样本
- 回顾性队列研究(证据等级III),纳入2016年1月至2021年4月在本机构接受初次全膝关节置换术的全部10,072例患者。
- 收集患者年龄、性别、种族、体重指数、美国麻醉医师协会(ASA)分级等基线资料,以及术后住院期间每日阿片类药物处方剂量和类型,换算为住院期间每日吗啡毫克当量(MME)以比较随时间变化的阿片类药物使用率。
主要发现
- 每日阿片类药物使用量最高为2016年(43.2±68.6 MME/天),最低为2021年(15.0±29.2 MME/天)。
- 线性回归分析发现术后阿片类药物消耗随时间呈显著线性下降趋势,每年减少5.55 MME/天(校正R方0.982,P<.001)。
- 最高视觉模拟量表(VAS)评分2016年为4.45,2021年为3.79(P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In response to physician and patient concerns, many institutions have adopted protocols aimed at reducing postoperative opioid consumption after total knee arthroplasty (TKA). Thus, this study sought to examine how consumption of opioids has changed following TKA in the past 6 years. METHODS: We conducted a retrospective review of all 10,072 patients who received primary TKA at our institution from January 2016 to April 2021. We collected baseline demographic data including patient age, sex, race, body mass index (BMI), American Society of Anesthesiologist (ASA) classification, as well as dosage and type of opioid medication prescribed on each postoperative day while the patient was hospitalized following TKA. This data was converted to milligram morphine equivalents (MME) per day hospitalized to compare rates of opioid use over time. RESULTS: Our analysis found the greatest daily opioid use was in 2016 (43.2 ± 68.6 MME/day) and the least was in 2021 (15.0 ± 29.2 MME/day). Linear regression analyses found a significant linear downward trend in postoperative opioid consumption over time, with a decrease of 5.55 MME per day per year (Adjusted R-squared: 0.982, P < .001). The highest visual analog scale (VAS) score was 4.45 in 2016 and the lowest was 3.79 in 2021 (P < .001). CONCLUSION: Opioid reducing protocols have been implemented for patients recovering from primary TKA in an effort to decrease reliance on opioids for postoperative pain control. The results of this study demonstrate that such protocols have been successful in reducing overall opioid use during hospitalization following TKA. LEVEL III EVIDENCE: Retrospective Cohort.
引用
- Christensen TH, Gemayel AC, Bieganowski T, et al. Opioid Use During Hospitalization Following Total Knee Arthroplasty: Trends in Consumption From 2016 to 2021. J Arthroplasty. 2023. PMID: 37019314. doi:10.1016/j.arth.2023.03.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。